| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K24690302 |
| PharmacoGx | BRD-K24690302 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZMYND19 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | CEACAM4 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | POU6F2 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | EMC2 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | FST | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | CPLX2 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | LCN15 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | TPMT | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | NOS3 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | C6orf1 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
